BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2885278)

  • 21. Efficient transformation of previously activated and dividing T lymphocytes by human T cell leukemia-lymphoma virus.
    Merl S; Kloster B; Moore J; Hubbell C; Tomar R; Davey F; Kalinowski D; Planas A; Ehrlich G; Clark D
    Blood; 1984 Nov; 64(5):967-74. PubMed ID: 6333258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional properties of antigen-specific T cells infected by human T-cell leukemia-lymphoma virus (HTLV-I).
    Mitsuya H; Guo HG; Cossman J; Megson M; Reitz MS; Broder S
    Science; 1984 Sep; 225(4669):1484-6. PubMed ID: 6206569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro infection of CD4+ T lymphocytes with HTLV-I generates immortalized cell lines coexpressing lymphoid and myeloid cell markers.
    Tricarico M; Macchi B; D'Atri S; Morrone S; Bonmassar E; Fuggetta MP; Graziani G
    Leukemia; 1999 Feb; 13(2):222-9. PubMed ID: 10025896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immortalization of human T lymphocytes by HTLV-I: phenotypic characteristics of target cells and kinetics of virus integration and expression.
    Del Mistro A; De Rossi A; Aldovini A; Salmi R; Chieco-Bianchi L
    Leuk Res; 1986; 10(9):1109-20. PubMed ID: 3020320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transformation of hamster spleen lymphocytes by human T-cell leukemia virus type I.
    Akagi T; Takata H; Ohtsuki Y; Takahashi K; Oka T; Yano S; Miyoshi I
    Int J Cancer; 1986 May; 37(5):775-9. PubMed ID: 3009333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection of human T lymphotropic virus-I-specific immune T cell clones by human T lymphotropic virus-I.
    Mitsuya H; Jarrett RF; Cossman J; Cohen OJ; Kao CS; Guo HG; Reitz MS; Broder S
    J Clin Invest; 1986 Nov; 78(5):1302-10. PubMed ID: 2877011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
    Ohashi T; Hanabuchi S; Suzuki R; Kato H; Masuda T; Kannagi M
    J Virol; 2002 Jul; 76(14):7010-9. PubMed ID: 12072501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection of rats with HTLV-1: a small-animal model for HTLV-1 carriers.
    Suga T; Kameyama T; Kinoshita T; Shimotohno K; Matsumura M; Tanaka H; Kushida S; Ami Y; Uchida M; Uchida K
    Int J Cancer; 1991 Nov; 49(5):764-9. PubMed ID: 1682281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immortalization of peripheral blood lymphocytes of cats by human T-cell leukemia virus.
    Hoshino H; Tanaka H; Shimotohno K; Miwa M; Nagai M; Shimoyama M; Sugimura T
    Int J Cancer; 1984 Oct; 34(4):513-7. PubMed ID: 6092283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low concentrations of suramin can reduce in vitro infection of human cord blood lymphocytes with HTLV-I during long-term culture.
    Pesce CD; Ciprani F; D'Onofrio C; Alvino E; Perno CF; Bonmassar E; CaliĆ² R
    Antiviral Res; 1987 Dec; 8(5-6):247-60. PubMed ID: 2897831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional modifications of alloreactive T cell clones infected with HTLV-I.
    Suciu-Foca N; Rubinstein P; Rohowsky-Kochan C; Cai J; Popovic M; Gallo RC; King DW
    J Immunol; 1986 Aug; 137(4):1115-9. PubMed ID: 3016087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia.
    Longo DL; Gelmann EP; Cossman J; Young RA; Gallo RC; O'Brien SJ; Matis LA
    Nature; 1984 Aug 9-15; 310(5977):505-6. PubMed ID: 6087161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells.
    Lo KM; Vivier E; Rochet N; Dehni G; Levine H; Haseltine WA; Anderson P
    J Immunol; 1992 Dec; 149(12):4101-8. PubMed ID: 1460293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus production and surface marker expression in human lymphocytes immortalized following dual infection with human T-cell leukemia virus and Epstein-Barr virus.
    Mochizuki S; Kawamura K; Maruyama K
    Int J Cancer; 1986 Apr; 37(4):551-6. PubMed ID: 3007374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Location of human T-cell leukemia virus (HTLV) p19 antigen on virus-producing cells.
    Aoki T; Hamada C; Ohno S; Miyakoshi H; Koide H; Robert-Guroff M; Ting RC; Gallo RC
    Int J Cancer; 1984 Feb; 33(2):161-5. PubMed ID: 6319298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal selection of human T-cell leukemia virus-infected cells in vivo and in vitro.
    Hahn B; Gallo RC; Franchini G; Popovic M; Aoki T; Salahuddin SZ; Markham PD; Staal FW
    Mol Biol Med; 1984 Feb; 2(1):29-36. PubMed ID: 6096666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T-cell leukemia virus type II transforms normal human lymphocytes.
    Chen IS; Quan SG; Golde DW
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):7006-9. PubMed ID: 6316341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
    Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
    J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.